Premature infants with patent ductus arteriosus: Postnatal growth according to type of management

Kunal Babla1, Theodore Dassios2, Kuberan Pushparajah3

  • 1Neonatal Intensive Care Unit, King's College Hospital NHS Foundation Trust, Denmark Hill, London, SE9 9RS, UK; GKT School of Medical Education, King's College London, London, UK.

Insights

Surgical management of Patent Ductus Arteriosus (PDA) in premature infants is linked to more significant growth impairment compared to medical or conservative approaches. This finding highlights potential long-term growth implications of PDA treatment strategies.

Area of Science:

  • Neonatology
  • Pediatric Cardiology
  • Growth and Development

Background:

  • Patent Ductus Arteriosus (PDA) is a common condition in preterm infants, particularly those born before 28 weeks' gestation.
  • PDA is associated with impaired growth, but the impact of different management strategies on growth faltering is not well understood.

Purpose of the Study:

  • To compare weight gain at 36 weeks' corrected gestational age (CGA) in premature infants managed medically, surgically, or conservatively for PDA.
  • To investigate the association between PDA treatment modality and growth impairment in preterm infants.

Main Methods:

  • Retrospective review of 208 infants born before 30 weeks' gestation with PDA.
  • Data collected included gestational age at birth, birth weight z-score, and weight z-score at 36 weeks' CGA.
  • Infants underwent surgical closure if they remained symptomatic after medical or conservative management.

Main Results:

  • Surgically managed infants had a lower median gestational age at birth compared to medically or conservatively managed infants.
  • No difference in birth weight z-scores was observed across the groups.
  • Surgically managed infants showed a significantly greater decrease in weight z-score from birth to 36 weeks' CGA compared to other groups, even after adjusting for gestational age at birth.

Conclusions:

  • Premature infants with PDA treated surgically experienced more pronounced growth faltering by 36 weeks' corrected gestational age.
  • The findings suggest that the chosen management strategy for PDA may influence long-term growth outcomes in preterm infants.
Abstract

Related Concept Videos

Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
159
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
270
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
152
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
225
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
186
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
170